Impact of Fibroblast Growth Factor 23 (FGF-23) and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients
NCT00903578 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2009-12-17
Summary
The present study will examine whether serum FGF-23 and serum phosphate at baseline of kidney transplant recipients can predict progression of allograft dysfunction at 3 years and all-cause mortality at 5 years.
Conditions
- Kidney Transplantation
Sponsors & Collaborators
-
Ramathibodi Hospital
lead OTHER
Principal Investigators
-
Sinee Disthabanchong, M.D. · Ramathibodi Hospital, Mahidol University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
Countries
- Thailand
More Related Trials
-
The Study of Long-term Deterioration of Kidney Transplants.
NCT00217126 ·Status: COMPLETED
-
Allograft Dysfunction in Heart Transplant
NCT03102125 ·Status: RECRUITING ·Phase: PHASE4
-
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
NCT05033548 ·Status: TERMINATED
-
Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient
NCT03193073 ·Status: SUSPENDED ·Phase: NA
-
The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation
NCT00056784 ·Status: COMPLETED
-
Evaluation of Advanced US Tools in Assessing Allograft Complications
NCT04423458 ·Status: COMPLETED
-
Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients
NCT00308802 ·Status: COMPLETED
-
Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
NCT00497926 ·Status: TERMINATED ·Phase: PHASE2
-
Estimating Glomerular Filtration Rate in Kidney Transplant Recipients
NCT05229939 ·Status: COMPLETED
-
Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation
NCT00110656 ·Status: COMPLETED
-
Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation
NCT02294097 ·Status: UNKNOWN ·Phase: NA
-
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
NCT05907096 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Blood Biomarkers in Pediatric Kidney Transplant Recipients
NCT05477082 ·Status: ACTIVE_NOT_RECRUITING
-
Renal Allograft Fibrosis Study
NCT05058170 ·Status: ENROLLING_BY_INVITATION
-
A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids
NCT00273559 ·Status: UNKNOWN
-
Use of Predigraft in Kidney Transplant Patients
NCT04969757 ·Status: COMPLETED ·Phase: NA
-
Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation
NCT02080117 ·Status: COMPLETED
-
A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-contrast Functional Magnetic Resonance Imaging
NCT07333495 ·Status: RECRUITING
-
Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
NCT01675089 ·Status: COMPLETED ·Phase: PHASE4
-
Bone and Cardiovascular Disease After Kidney Transplant
NCT02751099 ·Status: UNKNOWN
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
NCT06877169 ·Status: RECRUITING ·Phase: NA
-
Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
NCT06794203 ·Status: RECRUITING
-
The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation
NCT03018041 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers of Aging as Predictors of Kidney Transplant Function
NCT02335333 ·Status: COMPLETED
-
Evaluation of CAF22 After Renal Transplantation
NCT02346968 ·Status: COMPLETED